Chemoinformaics analysis of 3-Hydroxytirucalla-8,24-diene-21-oic acid
| Molecular Weight | 815.007 | nRot | 10 |
| Heavy Atom Molecular Weight | 744.447 | nRig | 38 |
| Exact Molecular Weight | 814.471 | nRing | 7 |
| Solubility: LogS | -3.231 | nHRing | 3 |
| Solubility: LogP | 1.756 | No. of Aliphatic Rings | 7 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 127 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 57 | No. of Aromatic Carbocycles | 0 |
| nHetero | 15 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 70 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 42 | No. of Saturated Rings | 6 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 15 | No. of Arom Bond | 0 |
| nHA | 15 | APOL | 128.846 |
| nHD | 6 | BPOL | 85.8485 |
| QED | 0.175 |
| Synth | 6.279 |
| Natural Product Likeliness | 2.346 |
| NR-PPAR-gamma | 0.024 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.599 |
| Pgp-sub | 0.063 |
| HIA | 0.258 |
| CACO-2 | -5.194 |
| MDCK | 0.000147897 |
| BBB | 0.033 |
| PPB | 0.307835 |
| VDSS | 0.278 |
| FU | 0.222673 |
| CYP1A2-inh | 0 |
| CYP1A2-sub | 0.597 |
| CYP2c19-inh | 0.001 |
| CYP2c19-sub | 0.851 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.022 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.13 |
| CYP3a4-inh | 0.013 |
| CYP3a4-sub | 0.714 |
| CL | 4.02 |
| T12 | 0.012 |
| hERG | 0.081 |
| Ames | 0.111 |
| ROA | 0.991 |
| SkinSen | 0.004 |
| Carcinogencity | 0.101 |
| EI | 0.002 |
| Respiratory | 0.029 |
| NR-Aromatase | 0.734 |
| Antiviral | Yes |
| Prediction | 0.852466 |